A rise in tuberculosis cases in Malaysia triggered social media posts falsely claiming that the bacteria responsible for the ...
The CDC’s changes threaten to cut vaccine sales for makers including Pfizer, Moderna, Merck and more, but a legal expert ...
Pharma groups like $113 bln Sanofi and Pfizer have spent years investing in immunisations. But scepticism from the US ...
Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.
Novavax (NVAX) is back in focus after Q4 2025 results showed surprise profitability, with revenue of US$147.14 million and net income of US$17.53 million, supported by key vaccine partnerships and ...
Dr. Vinay Prasad, vaccine chief at the the U.S. Food and Drug Administration (FDA), said in an internal memo in November that ...
Federal policies under Robert F. Kennedy Jr. that are hostile to vaccines have “sent a chill through the entire industry,” one scientist said.
The whiplash over a new potential flu vaccine from Moderna, which went from rejected to approved for review in a matter of days, has illustrated a new reality plaguing the Cambridge biotech company ...
America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...
5don MSN
US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost
By Ahmed Aboulenein WASHINGTON, Feb 23 (Reuters) - U.S. Food and Drug Administration Commissioner Marty Makary on Monday defended his agency's position and record on mRNA vaccines, days after it ...
Commissioner Marty Makary defended his agency's position and record on mRNA vaccines, days after it changed course and agreed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results